Vertex Pharmaceuticals is a biopharmaceutical company based in Boston that discovers and develops medicines for serious diseases. Its main work centres on treatments for cystic fibrosis, a genetic condition affecting the lungs and other organs, and it also develops therapies for sickle cell disease, beta thalassemia, acute and neuropathic pain, and kidney disorders. Its customers are patients, physicians and healthcare systems, and it sells its products in markets around the world through its own commercial operations and partnerships.
Vertex Pharmaceuticals Incorporated is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code VRTX34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #77 of 1455 on the B3 Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendStrong
80/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average13.6%
From 52-week high-2.1%
MomentumStrong
77/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return16.7%
6-month return29.4%
12-month, skipping last month19.4%
Stability (higher is calmer)Fair
67/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)34.0%
Worst drawdown, 1 year (smaller is calmer)-20.0%
LiquidityFair
67/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.27M BRL
Zero-volume days18.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 65.18 – 89.01Daily closes, split-adjusted
Signals
50-day average84.17
200-day average76.65
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.88
Technical summary
Daily
Bullish
11 bullish · 1 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
80.12
Bullish
EMA 10
81.84
Bullish
SMA 20
81.92
Bullish
EMA 20
81.84
Bullish
SMA 50
84.17
Bullish
EMA 50
82.02
Bullish
SMA 100
80.11
Bullish
EMA 100
80.29
Bullish
SMA 200
76.65
Bullish
EMA 200
78.07
Bullish
Oscillators (daily)
RSI (14)
61.48
Neutral
MACD (12, 26)
-0.34
Bearish
Momentum (12)
10.88
Bullish
Stochastic %K (14)
98.43
Bearish
Williams %R (14)
-1.57
Bearish
CCI (20)
101.1
Bearish
Pivot points (classic, last session)
S3
85.88
S2
86.18
S1
86.61
Pivot
86.91
R1
87.34
R2
87.64
R3
88.07
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
